Zota Health Care Ratios

Zota Health Care Ltd Ratios

The Zota Health Care Ltd Ratios page provides a complete fundamental analysis of Zota Health Care Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Zota Health Care Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Zota Health Care Ltd (NSE: ZOTA, BSE: 538426) is currently trading at ₹1321, with a market capitalization of ₹40.07B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Zota Health Care Ltd remains a key stock for fundamental analysis using Zota Health Care Ltd Ratios.

Zota Health Care Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Zota Health Care Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Zota Health Care Ltd Ratios.

Historically, the Zota Health Care Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 83.14
• 2020: 0

The decline in Zota Health Care Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Zota Health Care Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 10.31.

Historical P/B trend:

• 2024: 10.31
• 2023: 13.63
• 2022: 8.82
• 2021: 8.35

Zota Health Care Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Zota Health Care Ltd P/S ratio currently stands at 7.52, an important part of Zota Health Care Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 7.52
• 2023: 6.74
• 2022: 5.09
• 2021: 5.67

The rising Zota Health Care Ltd P/S ratio indicates improved revenue valuation by investors.

Zota Health Care Ltd Price to Cash Flow Ratio (P/CF)

The Zota Health Care Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Zota Health Care Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 50.77
• 2020: 0

The declining Zota Health Care Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Zota Health Care Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Zota Health Care Ltd EV currently stands at ₹23.36B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 23.36B
• 2023: 13.11B
• 2022: 7.53B
• 2021: 7.53B

Zota Health Care Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Zota Health Care Ltd EV/EBITDA ratio is currently 0, a key metric in Zota Health Care Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 170.93
• 2022: 100.48
• 2021: 50.66

Stable Zota Health Care Ltd EV/EBITDA indicates balanced valuation.

Zota Health Care Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Zota Health Care Ltd D/E ratio is currently 0.62, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.62
• 2023: 1.06
• 2022: 0.56
• 2021: 0.17

Zota Health Care Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Zota Health Care Ltd ROE currently stands at -35.96%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -35.96
• 2023: -16.85
• 2022: -6.79
• 2021: 11.43

Declining ROE indicates pressure on profitability.

Zota Health Care Ltd Ratios Analysis Summary

The Zota Health Care Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Zota Health Care Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Zota Health Care Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.